Paediatrics & child health最新文献

筛选
英文 中文
Health insurance for all children in Quebec? Ethical reflections on the implementation of PL 83.
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-19 eCollection Date: 2024-12-01 DOI: 10.1093/pch/pxae071
Annie Liv, Patricia Li, Ryoa Chung, Samir Shaheen-Hussain, Saleem Razack, Joanne Liu, Gaucher Nathalie
{"title":"Health insurance for all children in Quebec? Ethical reflections on the implementation of PL 83.","authors":"Annie Liv, Patricia Li, Ryoa Chung, Samir Shaheen-Hussain, Saleem Razack, Joanne Liu, Gaucher Nathalie","doi":"10.1093/pch/pxae071","DOIUrl":"10.1093/pch/pxae071","url":null,"abstract":"<p><p>The adoption of Projet de loi 83 (PL83) in 2021 aimed to grant previously uninsured migrant children in Quebec access to provincial public health insurance. Three years later, health professionals continue to encounter children who should be eligible for provincial insurance through PL83 but remain uninsured and who face various structural barriers that contribute to this limited access (language, administrative navigation, and access to information). This commentary, based on the conceptual framework of the ethics of care, considers autonomy as the ability to make one's own choices with support from others. Contrary to a conception of autonomy as self-sufficiency, the ethics of care encourages the design of policies and implementation measures capable of helping vulnerable individuals overcome barriers. In the case of access to healthcare for migrant children, we suggest presumptive eligibility and raising awareness among all key stakeholders who interact with parents, from admission and administrative staff to physicians.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 8","pages":"528-530"},"PeriodicalIF":1.8,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11840254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143483820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anorexia nervosa with comorbid autism spectrum disorder: Optimizing care for youth, caregivers, and health care providers. 神经性厌食症合并自闭症谱系障碍:优化对青少年、照顾者和医疗服务提供者的护理。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-11 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae022
Alon Coret, Holly Agostino
{"title":"Anorexia nervosa with comorbid autism spectrum disorder: Optimizing care for youth, caregivers, and health care providers.","authors":"Alon Coret, Holly Agostino","doi":"10.1093/pch/pxae022","DOIUrl":"10.1093/pch/pxae022","url":null,"abstract":"<p><p>Youth with anorexia nervosa (AN) have been reported to have high levels of comorbid autism spectrum disorder (ASD) and ASD-like traits suggesting a potential shared underlying neurodevelopmental or genetic link between the disorders. Youth with comorbid AN and ASD symptomatology generally require more intensive treatment and have worse psychological outcomes following treatment. To date, no Canadian national guidelines exist for the treatment of this comorbidity. An informal survey of tertiary paediatric eating disorder programs across Canada revealed that centres do not routinely screen for ASD at intake and few offer any treatment modifications for youth with AN and suspected/diagnosed comorbid ASD. This represents a significant care gap for this clinical sub-population and an important area for future study and healthcare provider training.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"374-377"},"PeriodicalIF":1.8,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor on the Canadian Paediatric Society statement on gender-affirming care. 对加拿大儿科学会关于性别确认护理声明的致编辑信的回应。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-10 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae066
Ashley Vandermorris, Dan Metzger, Ellie Vyver, Megan Harrison, Johanne Harvey
{"title":"Response to the Letter to the Editor on the Canadian Paediatric Society statement on gender-affirming care.","authors":"Ashley Vandermorris, Dan Metzger, Ellie Vyver, Megan Harrison, Johanne Harvey","doi":"10.1093/pch/pxae066","DOIUrl":"10.1093/pch/pxae066","url":null,"abstract":"","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"415-416"},"PeriodicalIF":1.8,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mixed-methods exploration of the Real-Time Virtual Support pathway Child Health Advice in Real-Time Electronically in Northwestern BC. 不列颠哥伦比亚省西北部电子实时儿童健康咨询实时虚拟支持途径的混合方法探索。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-10 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae063
Sean Duke, Jenna Treissman, Shannon Freeman, Emma Rossnagel, Salima Somani, Alam Lakhani, Kirsten Miller, John Pawlovich, David Wensley
{"title":"A mixed-methods exploration of the Real-Time Virtual Support pathway Child Health Advice in Real-Time Electronically in Northwestern BC.","authors":"Sean Duke, Jenna Treissman, Shannon Freeman, Emma Rossnagel, Salima Somani, Alam Lakhani, Kirsten Miller, John Pawlovich, David Wensley","doi":"10.1093/pch/pxae063","DOIUrl":"10.1093/pch/pxae063","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the implementation of a provincial virtual paediatric consulting service, Child Health Advice in Real-Time Electronically (CHARLiE), integrated into the paediatric on-call schedule in Northwestern British Columbia.</p><p><strong>Methods: </strong>Healthcare providers in Northwestern British Columbia responded to a survey (n = 72) and participated in focus groups (n = 35) and key informant interviews (n = 4) to share their experiences engaging in a healthcare model that incorporated virtual paediatric consultants in lieu of in-person local paediatrician coverage over a 28-month period. Survey data was analyzed using descriptive statistics. Themes were generated from a qualitative descriptive approach to focus groups and key informant interview transcripts.</p><p><strong>Results: </strong>96.1% of survey respondents who had used CHARLiE rated it as 'good' or 'very good' in the provision of overall support, while 77.6% reported that CHARLiE improved access to paediatric care. Focus group and key informant interview participants valued CHARLiE's timely, dedicated virtual bedside assessments of patients; collegiality and professionalism; amelioration of local paediatrician burnout; prevention of unnecessary transfers; and offloading of indirect patient care tasks. Video support improved provider confidence and appeared to improve caregiver trust. Suggested improvements included addressing technological barriers, enhancing providers' knowledge of local resources, and enabling continuity of care. Participants identified that virtual care does not replace on-the-ground specialist care.</p><p><strong>Conclusions: </strong>Participants valued CHARLiE's 24/7, timely, and collegial video support. While maintaining a full complement of on-the-ground paediatricians remains the goal for some rural communities, dedicated virtual support provides access to paediatric care in smaller communities, thereby improving health equity for children in British Columbia.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"346-353"},"PeriodicalIF":1.8,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Response to the Canadian Paediatric Position Statement on transgender and gender-diverse youth. 致编辑的信:对《加拿大儿科关于变性和性别多元化青年的立场声明》的回应。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-07 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae070
Chan Kulatunga Moruzi, Ian Mitchell, Darrell Palmer, Roxanne Goldade
{"title":"Letter to the Editor: Response to the Canadian Paediatric Position Statement on transgender and gender-diverse youth.","authors":"Chan Kulatunga Moruzi, Ian Mitchell, Darrell Palmer, Roxanne Goldade","doi":"10.1093/pch/pxae070","DOIUrl":"10.1093/pch/pxae070","url":null,"abstract":"","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"413-414"},"PeriodicalIF":1.8,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to my Younger Colleagues: "Don't cry because it's over…". 致年轻同事的信:"别哭,因为一切都结束了......"。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-10-04 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae054
Ellen Wood
{"title":"Letter to my Younger Colleagues: \"Don't cry because it's over…\".","authors":"Ellen Wood","doi":"10.1093/pch/pxae054","DOIUrl":"https://doi.org/10.1093/pch/pxae054","url":null,"abstract":"","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"411-412"},"PeriodicalIF":1.8,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Critical Lens: It is time to start using the right test for febrile young infants. 关键视角:是时候开始对发热的幼儿使用正确的检测方法了。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-09-30 eCollection Date: 2024-11-01 DOI: 10.1093/pch/pxae069
Adiel Marom, Jesse Papenburg, Brett Burstein
{"title":"The Critical Lens: It is time to start using the right test for febrile young infants.","authors":"Adiel Marom, Jesse Papenburg, Brett Burstein","doi":"10.1093/pch/pxae069","DOIUrl":"10.1093/pch/pxae069","url":null,"abstract":"<p><p>Fever among infants in the first months of life is a common clinical conundrum facing all clinicians who treat children. Most well-appearing febrile young infants have viral illnesses. However, it is critical to identify those at risk of invasive bacterial infections, specifically bacteremia and bacterial meningitis. Clinicians must balance the risks of missing these infections against the harms of over-investigation. Procalcitonin testing is currently the best diagnostic test available to help guide management, and the Canadian Paediatric Society Position Statement on the management of febrile young infants recommends procalcitonin-based risk stratification. However, in many clinical settings, procalcitonin is either unavailable or has a turnaround time that is too long to aid decision-making. Clinicians who care for febrile young infants must have rapid access to procalcitonin results to provide best-evidence, guideline-adherent care. The wider availability of this test is essential to reduce unnecessary invasive testing, hospitalizations, and antibiotic exposure and could reduce system-wide resource utilization.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 7","pages":"419-421"},"PeriodicalIF":1.8,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene-based drug therapy for children and youth treated with psychoactive medications. 为接受精神药物治疗的儿童和青少年提供基于基因的药物治疗。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-09-13 eCollection Date: 2024-08-01 DOI: 10.1093/pch/pxae029
Ruud H J Verstegen, Iris Cohn, Mark E Feldman, Daniel Gorman, Shinya Ito
{"title":"Gene-based drug therapy for children and youth treated with psychoactive medications.","authors":"Ruud H J Verstegen, Iris Cohn, Mark E Feldman, Daniel Gorman, Shinya Ito","doi":"10.1093/pch/pxae029","DOIUrl":"https://doi.org/10.1093/pch/pxae029","url":null,"abstract":"<p><p>Psychoactive medications are increasingly used to treat children and youth with mental health conditions, but individual variations in response highlight the need for precision medicine. Pharmacogenetic (PGx) testing is a key component of precision medicine. The number of commercial pharmacogenetic testing companies promoting PGx, with the promise of achieving individualized and effective treatment of mental health conditions, has grown exponentially in recent years. Scientific evidence supporting the use of PGx to manage mental health conditions is limited, especially for paediatric populations. This practice point outlines steps guiding the use and interpretation of PGx testing for psychoactive medications in clinical settings, along with key supportive resources. Practice guidelines have been developed for variants in pharmacogenes encoding cytochrome P450 drug-metabolizing enzymes (e.g., <i>CYP2C19</i>, <i>CYP2D6</i>, <i>CYP2C9</i>) as one determinant of drug concentrations in blood, which can support both drug choice and dosing strategy for certain anti-psychotics, anti-depressants, and anti-epileptics. Adverse drug reactions to some anti-epileptic drugs (e.g., carbamazepine and phenytoin) have been associated with certain human leukocyte antigen types and variants in DNA polymerase gamma (<i>POLG</i>; valproic acid). Evidence remains limited for genetic variants of drug target proteins, making it challenging to identify patients with altered treatment responses at a therapeutic blood concentration.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 5","pages":"311-323"},"PeriodicalIF":1.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11398941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving cycling safety for children and youth. 改善儿童和青少年的骑车安全。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-09-13 eCollection Date: 2024-08-01 DOI: 10.1093/pch/pxae035
Daniel Rosenfield, Pamela Fuselli, Suzanne Beno
{"title":"Improving cycling safety for children and youth.","authors":"Daniel Rosenfield, Pamela Fuselli, Suzanne Beno","doi":"10.1093/pch/pxae035","DOIUrl":"https://doi.org/10.1093/pch/pxae035","url":null,"abstract":"<p><p>Cycling remains a popular activity for children and youth around the world, combining the fun of moving at speed with numerous health and societal benefits. However, cycling is also associated with risk for serious injury and death. Over the past decade, research has increasingly shown that improving safety for cyclists depends, in large part, on the environment they are cycling in as well as on individual safety measures such as helmet use. The pandemic provided greater opportunity for many children and youth to engage in cycling, and refocused public attention on safer cycling infrastructure such as protected bike lanes. This statement reviews the evidence supporting safer cycling infrastructure for children and youth along with the physical and mental health benefits of cycling. The advantages of active transportation for young people, and how the built environment influences their cycling safety and uptake, are discussed. An overview of measures individuals can take to improve cycling safety is followed by recommendations for clinicians, the cycling community, parents, and policy-makers.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 5","pages":"324-334"},"PeriodicalIF":1.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11398925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La pharmacothérapie en fonction des gènes chez les enfants et les adolescents qui prennent des médicaments psychoactifs. 服用精神药物的儿童和青少年的基因依赖性药物疗法。
IF 1.8 4区 医学
Paediatrics & child health Pub Date : 2024-09-13 eCollection Date: 2024-08-01 DOI: 10.1093/pch/pxae028
Ruud H J Verstegen, Iris Cohn, Mark E Feldman, Daniel Gorman, Shinya Ito
{"title":"La pharmacothérapie en fonction des gènes chez les enfants et les adolescents qui prennent des médicaments psychoactifs.","authors":"Ruud H J Verstegen, Iris Cohn, Mark E Feldman, Daniel Gorman, Shinya Ito","doi":"10.1093/pch/pxae028","DOIUrl":"https://doi.org/10.1093/pch/pxae028","url":null,"abstract":"<p><p>Les médicaments psychoactifs sont de plus en plus utilisés pour traiter les enfants et les adolescents ayant des troubles de santé mentale, mais la variabilité des réponses individuelles fait ressortir l'importance d'une médecine personnalisée. Les tests pharmacogénétiques sont un volet important d'un tel type de médecine. Le nombre d'entreprises de tests pharmacogénétiques commerciaux qui font la promotion de tests de ce genre et promettent un traitement efficace et individualisé des troubles de santé mentale se multiplie depuis quelques années. Les preuves scientifiques en appui à l'utilisation de la pharmacogénétique sont limitées, particulièrement dans les populations pédiatriques. Le présent point de pratique souligne les étapes qui orientent le recours à ces tests pour la prise de médicaments psychoactifs en milieu clinique et présente des ressources de soutien importantes. Il existe des directives cliniques sur les variants des pharmacogènes qui encodent les enzymes de métabolisation du cytochrome P450 (p. ex., <i>CYP2C19</i>, <i>CYP2D6</i>, <i>CYP2C9</i>), lesquels sont l'un des déterminants des concentrations pharmacologiques dans le sang et peuvent appuyer à la fois le choix du médicament et la stratégie posologique de certains antipsychotiques, antidépresseurs et antiépileptiques. Les effets indésirables de certains médicaments antiépileptiques (p. ex., la carbamazépine et la phénytoïne) sont associés à certains types d'antigènes d'histocompatibilité humaine et à des variants de l'ADN polymérase gamma (<i>POLG</i>; acide valproïque). Les données probantes sont limitées à l'égard des variants génétiques des protéines qui ciblent les médicaments, et c'est pourquoi il est difficile de déterminer quels patients présenteraient une réponse altérée au traitement à une concentration sanguine thérapeutique.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 5","pages":"311-323"},"PeriodicalIF":1.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11398932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信